Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 305

1.

Purification of Pharmaceutical Solvents by Pervaporation through Hybrid Silica Membranes.

La Rocca T, Carretier E, Dhaler D, Louradour E, Truong T, Moulin P.

Membranes (Basel). 2019 Jul 1;9(7). pii: E76. doi: 10.3390/membranes9070076.

2.

GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis.

Grenet G, Ribault S, Nguyen GB, Glais F, Metge A, Linet T, Kassai-Koupai B, Cornu C, Bejan-Angoulvant T, Erpeldinger S, Boussageon R, Gouraud A, Bonnet F, Cucherat M, Moulin P, Gueyffier F.

PLoS One. 2019 Jun 25;14(6):e0217701. doi: 10.1371/journal.pone.0217701. eCollection 2019.

3.

Quantification of soil organic carbon stock in urban soils using visible and near infrared reflectance spectroscopy (VNIRS) in situ or in laboratory conditions.

Allory V, Cambou A, Moulin P, Schwartz C, Cannavo P, Vidal-Beaudet L, Barthès BG.

Sci Total Environ. 2019 Oct 10;686:764-773. doi: 10.1016/j.scitotenv.2019.05.192. Epub 2019 May 16.

PMID:
31195284
4.

Milk polar lipids reduce lipid cardiovascular risk factors in overweight postmenopausal women: towards a gut sphingomyelin-cholesterol interplay.

Vors C, Joumard-Cubizolles L, Lecomte M, Combe E, Ouchchane L, Drai J, Raynal K, Joffre F, Meiller L, Le Barz M, Gaborit P, Caille A, Sothier M, Domingues-Faria C, Blot A, Wauquier A, Blond E, Sauvinet V, Gésan-Guiziou G, Bodin JP, Moulin P, Cheillan D, Vidal H, Morio B, Cotte E, Morel-Laporte F, Laville M, Bernalier-Donadille A, Lambert-Porcheron S, Malpuech-Brugère C, Michalski MC.

Gut. 2019 Jun 12. pii: gutjnl-2018-318155. doi: 10.1136/gutjnl-2018-318155. [Epub ahead of print]

PMID:
31189655
5.

Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis.

Grenet G, Le HH, Bejan-Angoulvant T, Erpeldinger S, Boussageon R, Kassaï B, Moulin P, Gueyffier F, Cucherat M.

Diabetes Metab. 2019 May 28. pii: S1262-3636(19)30085-0. doi: 10.1016/j.diabet.2019.05.003. [Epub ahead of print]

PMID:
31150802
6.

Effects of Operating Parameters on Ionic Liquid Membrane to Remove Humidity in a Green Continuous Process.

Yan X, Favard A, Anguille S, Bendahan M, Moulin P.

Membranes (Basel). 2019 May 24;9(5). pii: E65. doi: 10.3390/membranes9050065.

7.

Large triglyceride-rich lipoproteins from fasting patients with type 2 diabetes activate platelets.

Boulet MM, Cheillan D, Di Filippo M, Buisson C, Michalski MC, Moulin P, Calzada C.

Diabetes Metab. 2019 Apr 11. pii: S1262-3636(19)30059-X. doi: 10.1016/j.diabet.2019.03.002. [Epub ahead of print]

PMID:
30981822
8.

Normal serum ApoB48 and red cells vitamin E concentrations after supplementation in a novel compound heterozygous case of abetalipoproteinemia.

Di Filippo M, Collardeau Frachon S, Janin A, Rajan S, Marmontel O, Decourt C, Rubio A, Nony S, Dumont S, Cuerq C, Charrière S, Moulin P, Lachaux A, Hussain MM, Bozon D, Peretti N.

Atherosclerosis. 2019 May;284:75-82. doi: 10.1016/j.atherosclerosis.2019.02.016. Epub 2019 Mar 3.

PMID:
30875496
9.

Defining the Role of the Streptococcus agalactiae Sht-Family Proteins in Zinc Acquisition and Complement Evasion.

Moulin P, Rong V, Ribeiro E Silva A, Pederick VG, Camiade E, Mereghetti L, McDevitt CA, Hiron A.

J Bacteriol. 2019 Mar 26;201(8). pii: e00757-18. doi: 10.1128/JB.00757-18. Print 2019 Apr 15.

PMID:
30745371
10.

Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score.

Moulin P, Dufour R, Averna M, Arca M, Cefalù AB, Noto D, D'Erasmo L, Di Costanzo A, Marçais C, Walther LAA, Banach M, Borén J, Cramb R, Gouni-Berthold I, Hughes E, Johnson C, Pintó X, Reiner Ž, van Lennep JR, Soran H, Stefanutti C, Stroes E, Bruckert E.

Data Brief. 2018 Oct 27;21:1334-1336. doi: 10.1016/j.dib.2018.10.125. eCollection 2018 Dec.

11.

On-Line NIR to Regulate Pervaporation Process: Application for Dehydration.

La Rocca T, Carretier E, Clair T, Etienne M, Moulin P.

Membranes (Basel). 2018 Sep 4;8(3). pii: E74. doi: 10.3390/membranes8030074.

12.

Development of a new method for measuring the abrasive potential of water: risk of membrane failure in water treatment plants.

Manon Y, Wyart Y, Fabre A, Brehant A, Bonnard R, Moulin P.

Water Sci Technol. 2018 Jul;77(11-12):2781-2793. doi: 10.2166/wst.2018.266.

PMID:
30065130
13.

Air Backwash Efficiency on Organic Fouling of UF Membranes Applied to Shellfish Hatchery Effluents.

Cordier C, Stavrakakis C, Sauvade P, Coelho F, Moulin P.

Membranes (Basel). 2018 Jul 23;8(3). pii: E48. doi: 10.3390/membranes8030048.

14.

New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia.

Serveaux Dancer M, Di Filippo M, Marmontel O, Valéro R, Piombo Rivarola MDC, Peretti N, Caussy C, Krempf M, Vergès B, Mahl M, Marçais C, Moulin P, Charrière S.

J Clin Lipidol. 2018 Sep - Oct;12(5):1244-1252. doi: 10.1016/j.jacl.2018.06.018. Epub 2018 Jul 7.

PMID:
30037590
15.

Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.

Cuerq C, Henin E, Restier L, Blond E, Drai J, Marçais C, Di Filippo M, Laveille C, Michalski MC, Poinsot P, Caussy C, Sassolas A, Moulin P, Reboul E, Charriere S, Levy E, Lachaux A, Peretti N.

J Lipid Res. 2018 Sep;59(9):1640-1648. doi: 10.1194/jlr.M085043. Epub 2018 Jul 18.

16.

Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".

Moulin P, Dufour R, Averna M, Arca M, Cefalù AB, Noto D, D'Erasmo L, Di Costanzo A, Marçais C, Alvarez-Sala Walther LA, Banach M, Borén J, Cramb R, Gouni-Berthold I, Hughes E, Johnson C, Pintó X, Reiner Ž, van Lennep JR, Soran H, Stefanutti C, Stroes E, Bruckert E.

Atherosclerosis. 2018 Aug;275:265-272. doi: 10.1016/j.atherosclerosis.2018.06.814. Epub 2018 Jun 18. Review.

17.

In vitro oxidized HDL and HDL from type 2 diabetes patients have reduced ability to efflux oxysterols from THP-1 macrophages.

Chen Y, Arnal-Levron M, Hullin-Matsuda F, Knibbe C, Moulin P, Luquain-Costaz C, Delton I.

Biochimie. 2018 Oct;153:232-237. doi: 10.1016/j.biochi.2018.04.018. Epub 2018 Apr 26.

PMID:
29704538
18.

Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy.

Marmontel O, Charrière S, Simonet T, Bonnet V, Dumont S, Mahl M, Jacobs C, Nony S, Chabane K, Bozon D, Janin A, Peretti N, Lachaux A, Bardel C, Millat G, Moulin P, Marçais C, Di Filippo M.

Clin Genet. 2018 Jul;94(1):132-140. doi: 10.1111/cge.13250. Epub 2018 Apr 25.

PMID:
29572815
19.

Lean body weight is the best scale for venous thromboprophylaxis algorithm in severely obese patients undergoing bariatric surgery.

Gaborit B, Moulin PA, Bege T, Boullu S, Vincentelli C, Emungania O, Morange PE, Berdah S, Salem JE, Dutour A, Frere C.

Pharmacol Res. 2018 May;131:211-217. doi: 10.1016/j.phrs.2018.02.012. Epub 2018 Feb 13.

PMID:
29452290
20.

Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?

Ghaleb Y, Elbitar S, El Khoury P, Bruckert E, Carreau V, Carrié A, Moulin P, Di-Filippo M, Charriere S, Iliozer H, Farnier M, Luc G, Rabès JP, Boileau C, Abifadel M, Varret M.

Eur J Hum Genet. 2018 Apr;26(4):570-578. doi: 10.1038/s41431-017-0078-y. Epub 2018 Jan 26.

21.

Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort.

Garnier L, Marchand L, Benoit M, Nicolino M, Bendelac N, Wright C, Moulin P, Lombard C, Thivolet C, Fabien N.

Clin Chim Acta. 2018 Mar;478:162-165. doi: 10.1016/j.cca.2017.12.043. Epub 2017 Dec 28.

PMID:
29288641
22.

Recurrent pancreatitis due to autoimmune hypertriglyceridemia in a patient with Graves' disease.

Álvarez-Uría A, Diéguez M, Moulin P.

Med Clin (Barc). 2018 Oct 12;151(7):295-296. doi: 10.1016/j.medcli.2017.11.016. Epub 2017 Dec 19. English, Spanish. No abstract available.

PMID:
29273424
23.

Performance of a biomass adapted to oncological ward wastewater vs. biomass from municipal WWTP on the removal of pharmaceutical molecules.

Hamon P, Moulin P, Ercolei L, Marrot B.

Water Res. 2018 Jan 1;128:193-205. doi: 10.1016/j.watres.2017.10.037. Epub 2017 Oct 20.

PMID:
29102698
24.

Southeast asian ovalocytosis: the need for a carefull observation of red cell indices and blood smear.

Moulin PA, Nivaggioni V, Saut N, Grosdidier C, Bernot D, Baccini V.

Ann Biol Clin (Paris). 2017 Dec 1;75(6):699-702. doi: 10.1684/abc.2017.1291.

PMID:
29043981
25.

Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus.

Ernande L, Audureau E, Jellis CL, Bergerot C, Henegar C, Sawaki D, Czibik G, Volpi C, Canoui-Poitrine F, Thibault H, Ternacle J, Moulin P, Marwick TH, Derumeaux G.

J Am Coll Cardiol. 2017 Oct 3;70(14):1704-1716. doi: 10.1016/j.jacc.2017.07.792.

26.

Alterations in plasma triglycerides lipolysis in patients with history of multifactorial chylomicronemia.

Marmontel O, Di Filippo M, Marcais C, Nony S, Dumoux M, Serveaux-Dancer M, Caussy C, Charrière S, Moulin P.

Atherosclerosis. 2017 Oct;265:22-28. doi: 10.1016/j.atherosclerosis.2017.07.030. Epub 2017 Jul 29.

PMID:
28829998
27.

Treatment of radioactive liquid effluents by reverse osmosis membranes: From lab-scale to pilot-scale.

Combernoux N, Schrive L, Labed V, Wyart Y, Carretier E, Moulin P.

Water Res. 2017 Oct 15;123:311-320. doi: 10.1016/j.watres.2017.06.062. Epub 2017 Jun 24.

PMID:
28675844
28.

The Utility of Gene Expression Profiling from Tissue Samples to Support Drug Safety Assessments.

Stiehl DP, Tritto E, Chibout SD, Cordier A, Moulin P.

ILAR J. 2017 Jul 1;58(1):69-79. doi: 10.1093/ilar/ilx016.

PMID:
28575330
29.

Xenobiotic CAR Activators Induce Dlk1-Dio3 Locus Noncoding RNA Expression in Mouse Liver.

Pouché L, Vitobello A, Römer M, Glogovac M, MacLeod AK, Ellinger-Ziegelbauer H, Westphal M, Dubost V, Stiehl DP, Dumotier B, Fekete A, Moulin P, Zell A, Schwarz M, Moreno R, Huang JTJ, Elcombe CR, Henderson CJ, Roland Wolf C, Moggs JG, Terranova R.

Toxicol Sci. 2017 Aug 1;158(2):367-378. doi: 10.1093/toxsci/kfx104.

PMID:
28541575
30.

Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.

Beigneux AP, Miyashita K, Ploug M, Blom DJ, Ai M, Linton MF, Khovidhunkit W, Dufour R, Garg A, McMahon MA, Pullinger CR, Sandoval NP, Hu X, Allan CM, Larsson M, Machida T, Murakami M, Reue K, Tontonoz P, Goldberg IJ, Moulin P, Charrière S, Fong LG, Nakajima K, Young SG.

N Engl J Med. 2017 Apr 27;376(17):1647-1658. doi: 10.1056/NEJMoa1611930. Epub 2017 Apr 5.

31.

Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases.

Poinsot P, Collardeau Frachon S, Restier L, Sérusclat A, Di Filippo M, Charrière S, Moulin P, Lachaux A, Peretti N.

J Clin Lipidol. 2017 Jan - Feb;11(1):167-177.e3. doi: 10.1016/j.jacl.2016.11.008. Epub 2016 Dec 6.

PMID:
28391883
32.

The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency.

Steinhagen-Thiessen E, Stroes E, Soran H, Johnson C, Moulin P, Iotti G, Zibellini M, Ossenkoppele B, Dippel M, Averna MR; GENIALL Investigators.

Atherosclerosis. 2017 Jul;262:146-153. doi: 10.1016/j.atherosclerosis.2016.08.023. Epub 2016 Aug 21. Review.

PMID:
28284702
33.

Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf-/- mouse model.

Chapeau EA, Gembarska A, Durand EY, Mandon E, Estadieu C, Romanet V, Wiesmann M, Tiedt R, Lehar J, de Weck A, Rad R, Barys L, Jeay S, Ferretti S, Kauffmann A, Sutter E, Grevot A, Moulin P, Murakami M, Sellers WR, Hofmann F, Jensen MR.

Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3151-3156. doi: 10.1073/pnas.1620262114. Epub 2017 Mar 6.

34.

Diastolic function deterioration in type 2 diabetes mellitus: predictive factors over a 3-year follow-up.

Bergerot C, Davidsen ES, Amaz C, Thibault H, Altman M, Bellaton A, Moulin P, Derumeaux G, Ernande L.

Eur Heart J Cardiovasc Imaging. 2018 Jan 1;19(1):67-73. doi: 10.1093/ehjci/jew331.

PMID:
28165130
35.

Consensus statement on the management of dyslipidaemias in adults.

French Society of Endocrinology (SFE); Francophone Society of Diabetes (SFD); New French Society of Atherosclerosis (NSFA), Béliard S, Bonnet F, Bouhanick B, Bruckert E, Cariou B, Charrière S, Durlach V, Moulin P, Valéro R, Vergès B.

Ann Endocrinol (Paris). 2017 Feb;78(1):43-53. doi: 10.1016/j.ando.2016.11.001. Epub 2017 Jan 12. No abstract available.

PMID:
28089403
36.

Incidental finding of 3 Southeast Asian ovalocytosis cases by attentive examination of blood smears.

Moulin PA, Baccini V.

Blood. 2017 Jan 5;129(1):133. doi: 10.1182/blood-2016-07-729855. No abstract available.

37.

Protocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta-analysis: GLUCOSE DINET protocol-Rational and design.

Grenet G, Lajoinie A, Ribault S, Nguyen GB, Linet T, Metge A, Cornu C, Cucherat M, Moulin P, Gueyffier F.

Fundam Clin Pharmacol. 2017 Jun;31(3):258-264. doi: 10.1111/fcp.12263. Epub 2017 Mar 23. Review.

PMID:
28036112
38.

Diagnostic algorithm for familial chylomicronemia syndrome.

Stroes E, Moulin P, Parhofer KG, Rebours V, Löhr JM, Averna M.

Atheroscler Suppl. 2017 Jan;23:1-7. doi: 10.1016/j.atherosclerosissup.2016.10.002. Epub 2016 Dec 18.

39.

Fatty acid dietary intake in the general French population: are the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) national recommendations met?

Tressou J, Moulin P, Vergès B, Le Guillou C, Simon N, Pasteau S.

Br J Nutr. 2016 Dec;116(11):1966-1973. doi: 10.1017/S000711451600413X. Epub 2016 Dec 20.

PMID:
27993183
40.

Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization.

Segueni N, Tritto E, Bourigault ML, Rose S, Erard F, Le Bert M, Jacobs M, Di Padova F, Stiehl DP, Moulin P, Brees D, Chibout SD, Ryffel B, Kammüller M, Quesniaux VF.

Sci Rep. 2016 Nov 17;6:36923. doi: 10.1038/srep36923.

41.

Lack of evidence for a liver or intestinal miRNA regulation involved in the hypertriglyceridemic effect of APOC3 3'UTR variant SstI.

Dancer M, Caussy C, Di Filippo M, Moulin P, Marçais C, Charrière S.

Atherosclerosis. 2016 Dec;255:6-10. doi: 10.1016/j.atherosclerosis.2016.10.024. Epub 2016 Oct 13.

PMID:
27794214
42.

Editor's Highlight: Comparative Renal Safety Assessment of the Hepatitis B Drugs, Adefovir, Tenofovir, Telbivudine and Entecavir in Rats.

Uteng M, Mahl A, Beckmann N, Piaia A, Ledieu D, Dubost V, Tritto E, Wolf A, Moulin P, Li L, Chibout SD, Pognan F.

Toxicol Sci. 2017 Jan;155(1):283-297. doi: 10.1093/toxsci/kfw208. Epub 2016 Oct 13.

PMID:
27742868
43.

A Fully-Automatic Method to Segment the Carotid Artery Layers in Ultrasound Imaging: Application to Quantify the Compression-Decompression Pattern of the Intima-Media Complex During the Cardiac Cycle.

Zahnd G, Kapellas K, van Hattem M, van Dijk A, Sérusclat A, Moulin P, van der Lugt A, Skilton M, Orkisz M.

Ultrasound Med Biol. 2017 Jan;43(1):239-257. doi: 10.1016/j.ultrasmedbio.2016.08.016. Epub 2016 Oct 12.

PMID:
27742139
44.

Perioperative thromboprophylaxis in severely obese patients undergoing bariatric surgery: insights from a French national survey.

Moulin PA, Dutour A, Ancel P, Morange PE, Bege T, Ziegler O, Berdah S, Frère C, Gaborit B.

Surg Obes Relat Dis. 2017 Feb;13(2):320-326. doi: 10.1016/j.soard.2016.08.497. Epub 2016 Sep 1.

PMID:
27720420
45.

The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients.

Béliard S, Millier A, Carreau V, Carrié A, Moulin P, Fredenrich A, Farnier M, Luc G, Rosenbaum D, Toumi M, Bruckert E; French FH Registry group.

J Clin Lipidol. 2016 Sep-Oct;10(5):1129-1136.e3. doi: 10.1016/j.jacl.2016.06.007. Epub 2016 Jun 27.

PMID:
27678429
46.

The Adc/Lmb System Mediates Zinc Acquisition in Streptococcus agalactiae and Contributes to Bacterial Growth and Survival.

Moulin P, Patron K, Cano C, Zorgani MA, Camiade E, Borezée-Durant E, Rosenau A, Mereghetti L, Hiron A.

J Bacteriol. 2016 Nov 18;198(24):3265-3277. Print 2016 Dec 15.

47.

Consensus statement on the management of dyslipidaemias in adults.

French Society of Endocrinology (SFE); Francophone Society of Diabetes (SFD); New French Society of Atherosclerosis (NSFA), Béliard S, Bonnet F, Bouhanick B, Bruckert E, Cariou B, Charrière S, Durlach V, Moulin P, Valéro R, Vergès B.

Diabetes Metab. 2016 Dec;42(6):398-408. doi: 10.1016/j.diabet.2016.07.033. Epub 2016 Sep 20. No abstract available.

48.

[Management of dyslipidemia in adult].

Béliard S, Bonnet F, Bouhanick B, Charrière S, Cariou B, Durlach V, Moulin P, Valéro R, Vergès B, Boccara F, Farnier M, Feve B, Gourdy P, Guerci B, Krempf M, Moulin P.

Rev Prat. 2016 Sep;66(7):727-41. French. No abstract available.

PMID:
30512287
49.

Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic mice.

Beckmann N, Doelemeyer A, Zurbruegg S, Bigot K, Theil D, Frieauff W, Kolly C, Moulin P, Neddermann D, Kreutzer R, Perrot L, Brzak I, Jacobson LH, Staufenbiel M, Neumann U, Shimshek DR.

Neurobiol Aging. 2016 Sep;45:50-60. doi: 10.1016/j.neurobiolaging.2016.05.009. Epub 2016 May 17.

50.

Results of Ponseti Brasil Program: Multicentric Study in 1621 Feet: Preliminary Results.

Nogueira MP, Queiroz AC, Melanda AG, Tedesco AP, Brandão AL, Beling C, Violante FH Jr, Brandão GF, Ferreira LF, Brambila LS, Leite LM, Zabeu JL, Kim JH, Fernandes KE, Arima MA, Aguilar MD, Farias Filho OC, Oliveira Filho OB, Pinho SD, Moulin P, Volpi R, Fox M, Greenwald MF, Lyle B, Morcuende JA.

J Pediatr Orthop. 2017 Apr/May;37(3):e197-e201. doi: 10.1097/BPO.0000000000000801.

PMID:
27280895

Supplemental Content

Loading ...
Support Center